Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Rheumatoid Arthritis
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Rheumatoid Arthritis
    Risk of TB Higher for Patients Taking Infliximab, Adalimumab, Than Etanercept - (DGNews)
    Golimumab Effective in Patients With RA Who Have Poor Response to Other Drugs - (DGNews)
    TopAbstracts in Rheumatoid Arthritis 06/25/2009 - (DGNews)
    Initial Therapy With Adalimumab Plus Methotrexate Leads to Better Outcomes Over 5 Years in Patients With Early Rheumatoid Arthritis: Presented at EULAR - (DGDispatch)
    Abatacept Plus Methotrexate Safe, Effective for Up to 5 Years in Patients With Rheumatoid Arthritis: Presented at EULAR - (DGDispatch)

    News archive

     Recent webcasts/CME - Rheumatoid Arthritis
    • Benefits of Early, Aggressive, and Appropriate Intervention in Rheumatoid Arthritis
    • Safety of Novel Immunomodulatory Therapies
      Rheumatoid Arthritis: The Heart of the Matter Assessing Cardiovascular Risk in Patients with Rheumatoid Arthritis
      New Recommendations for Disease-Modifying Antirheumatic Drugs and Emerging Options for the Treatment of Rheumatoid Arthritis
      Failing a TNF Inhibitor: What About Switching?

      Webcasts/CME archive

       Recent cases - Rheumatoid Arthritis
        Patient with Hepatitis B and Rheumatoid Arthritis
        Autologous Chondrocyte Implantation for Rheumatoid Arthritis of the Knee: A Case Report
        Complete Heart Block and Severe Aortic Stenosis in a Patient with Rheumatoid Arthtritis: A Case Report
        Limited Wegener's Granulomatosis Presenting as Lung Nodules in a Patient with Rheumatoid Arthritis: A Case Report
        Aseptic Meningitis in a Patient Taking Etanercept for Rheumatoid Arthritis: A Case Report

        Cases archive
          




        my personal edition > rheumatoid arthritis > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Proteus Infection May Be Linked to Rheumatoid Arthritis

        A DGReview of :"Antibacterial and antipeptide antibodies in Japanese and Finnish patients with rheumatoid arthritis"
        Clinical Rheumatology

        04/05/2004
        By Kurt V. Ullman, RN


        Patients with rheumatoid arthritis (RA) have been have significantly elevated IgG and IgM antibodies to Proteus mirabilis and antibodies to both EQRRAA and ESSRAL peptides, according researchers in both Finland and Japan.

        A total of 230 serum samples from patients with RA or systemic lupus erythematous (SLE) and from healthy controls were collected by T. Rashid and colleagues from Kings College in London, Helsinki University Hospital in Finland, the Shiga University of Medical Science, and Juntendo University, both in Japan. The subjects were then screened for total and class-specific antibodies against P. mirabilis, Escherichia coli and Serratia marcescens by indirect immunofluorescence assay. They were also tested to determine levels of isotypic antibodies against the shared epitope containing EQRRAA and ESSRAL peptides using enzyme-linked immunosorbent assay (ELISA).

        Elevated levels of Proteus IgG antibodies were seen in Finnish patients with early (<12 months) and advanced RA compared to healthy controls (P < .001 early, P < .001 advanced). Similar elevations of the IgM Proteus antibody were seen in both Finnish RA groups when compared to controls. This pattern also followed for Proteus IgG and IgM antibodies in the Japanese cohorts against both healthy controls and patients with SLE. In both countries, no significant increases in antibody levels were seen against either E. coli or S. marcescens.

        Significant elevations were mainly seen in the IgG class of antibodies to EQRRAA and ESRRAL peptides in both early and advanced RA patients in Finland. Again, the same basic pattern was seen in the Japanese patients when compared to healthy controls and those with SLE.

        Finally, when total antibody levels against each of the tested microorganisms were compared with antibodies to EQRRAA and ESRRAL peptides among both Finnish and Japanese patients with RA, significant correlations were only observed between anti-Proteus and anti-QQRRAA (R= .79, P < .001) and anti-ESRRAL (R=.86, P < .001) peptide antibodies. In contrast, no significant correlation was found between E. coli or Serratia antibodies and the two peptides.

        "Our findings of increased antibodies to Proteus but not E. coli or S. marcescens is a remarkable observation, as all these bacteria carry in their primary structure the homologous RA susceptibility sequence," said Dr. Rashid. "This characteristic provides strong evidence that RA patients have been infected by Proteus bacteria, probably in the upper respiratory tract, but not by E. coli or S. marcescens."



        Clin Rheumatol 2004 Apr;12:134-41. "Antibacterial and antipeptide antibodies in Japanese and Finnish patients with rheumatoid arthritis"

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send